Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy.
Document Type
Journal Article
Publication Date
2-1-2016
Journal
Arteriosclerosis, Thrombosis, and Vascular Biology
Volume
36
Issue
2
Inclusive Pages
418-24
DOI
10.1161/ATVBAHA.115.306905
APA Citation
Johnson, K. C., Aragaki, A. K., Jackson, R., Reiner, A., Sandset, P., Rosing, J., Dahm, A. E., Martin, L. W., & + 6 more (2016). Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy.. Arteriosclerosis, Thrombosis, and Vascular Biology, 36 (2). http://dx.doi.org/10.1161/ATVBAHA.115.306905
Peer Reviewed
1